Aroa Biosurgery Ltd (AU:ARX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aroa Biosurgery Limited has reported a strong performance for the quarter ending September 2024, with a 35% increase in cash receipts to NZ$19.9 million and a significant reduction in cash burn. The company remains debt-free with a robust cash balance of NZ$21.6 million and maintains its revenue guidance for FY25, while expanding its market presence in the US, Argentina, and Egypt.
For further insights into AU:ARX stock, check out TipRanks’ Stock Analysis page.